David A. Calhoun

Letters to the Editor will be published, if suitable, as space permits. They should not exceed 1000 words (typed, double-spaced) in length and may be subject to editing or abridgment.

Krishna K. Gaddam, David A. Calhoun, Catena C. Hyperaldosteronism, 2008 .

Drugs targeting the renin–angiotensin–aldosterone system

David A. Calhoun, S. Oparil, D. Calhoun, 2002, Nature Reviews Drug Discovery.